FDA Import Refusal SCS-6421404-3/31/1 — Pharmascience Inc.
The FDA refused shipment SCS-6421404-3/31/1 from Pharmascience Inc. (Canada) on Sep 25, 2019. The refused product falls under Drugs and Biologics — ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC). Cited charge: 118 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Sep 25, 2019
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61JIA08 ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
- Charges
- 118